Consequences attributed to poorly controlled and recurrent MDD are evaluated by Michael Rothrock, MBA, MHA, and H. Eric Cannon, PharmD, FAMCP. Michael Rothrock, MBA, MHA: The potential consequences of ...

—Being able to distinguish between recurrent and nonrecurrent depression subtypes around the time of the onset would allow both acute-phase therapies and prevention strategies to become more focused ...

Although antidepressants are a mainstay of MDD treatment, they are plagued by poor efficacy, high rates of relapse, and intolerable side effects. 40,41 Second-generation antidepressants, including ...

October is National Depression Screening Month, and this series of posts will focus on identifying and understanding the palette of variation in major depressive disorder (MDD). In the United States, ...